Skip to main content
Article thumbnail
Location of Repository

Macular corneal dystrophy in a Chinese family related with novel mutations of CHST6

By Xiuhong Dang, Qingguo Zhu, Li Wang, Hong Su, Hui Lin, Nan Zhou, Ting Liang, Zheng Wang, Shangzhi Huang, Qiushi Ren and Yanhua Qi
Topics: Research Article
Publisher: Molecular Vision
OAI identifier: oai:pubmedcentral.nih.gov:2666773
Provided by: PubMed Central

Suggested articles

Citations

  1. (2006). CHST6 mutations in North American subjects with macular corneal dystrophy: a comprehensive molecular genetic review.
  2. (1986). Corneal thinning in macular corneal dystrophy.
  3. (2009). Decreased GlcNAc 6-OSulfotransferase Activity in the Cornea with Macular Corneal Dystrophy. Invest Ophthalmol Vis Sci 2000; 41:3670-7. [PMID: 11053262] Molecular Vision
  4. (2008). Duncker.Macular corneal dystrophy: mutational spectrum in German patients, novel mutations and therapeutic options. Graefes Arch Clin Exp Ophthalmol
  5. (2006). Focus on molecules: CHST6 (carbohydrate sulfotransferase 6; corneal Nacetylglucosamine-6-sulfotransferase). Exp Eye Res
  6. (1998). Haplotype analysis in Icelandic families defines a minimal interval for the macular corneal dystrophy typeI gene.
  7. (1988). Heterogeneity in macular corneal dystrophy. Arch Ophthalmol
  8. (2001). Human corneal GlcNac 6-O-sulfotransferase and mouse intestinal GlcNac 6-O-sulfotransferase both produce keratan sulfate.
  9. (2003). Identification of novel mutation of the CHST6 gene in Vietnamese families affected with macular corneal dystrophy in two generations. Cornea
  10. (2002). Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy. Invest Ophthalmol Vis Sci
  11. (2001). Immunohistochemical classification of primery and recurrent macular corneal dystrophy in Germany: Subclassification of immunophenotype IA using a novel keratin sulfate antibody. Exp Eye Res
  12. (1988). Immunohistochemical evidence of heterogeneity in macular corneal dystrophy.
  13. (1996). Linkage of a gene for macular corneal dystrophy to chromosome 16.
  14. (1996). Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients. Ophthalmology
  15. (1989). Macular corneal dystrophy in Iceland. Eye
  16. (1997). Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype.
  17. (2000). Macular corneal dystrophy type I and type II is caused by distinct mutations in a new sulphotransferase gene. Nat Genet
  18. (2006). Macular corneal dystrophy types I and II are caused by distinct mutations in the CHST6 gene in Iceland. Mol Vis
  19. (2003). Mutation analysis of the carbohydrate sulfotransferase gene in Vietnamese with macular corneal dystrophy. Invest Ophthalmol Vis Sci
  20. (2000). Mutations in corneal carbohydrate sulfotransferase 6 gene (CHST6) cause macular corneal dystrophy in Iceland. Mol Vis
  21. (2003). Mutations in the CHST6 gene in patients with macular corneal dystrophy: immunohistochemical evidence of heterogeneity. Invest Ophthalmol Vis Sci
  22. (2005). Novel CHST6 nonsense and missense mutations responsible for macular corneal dystrophy.
  23. (2004). Novel mutations in the CHST6 gene causing macular corneal dystrophy. Clin Genet
  24. (2001). Novel mutations in the CHST6 gene in Saudi Arabic patients with macular corneal dystrophy. ARVO Annual Meeting;
  25. (2000). Physical and genetic mapping of the macular corneal dystrophy locus on chromosome 16q and exclusion of TAT and LCAT as candidate genes. Mol Vis
  26. (2003). Truncating mutations in the carbohydrate sulfotransferase 6 gene (CHST6) result in macular corneal dystrophy. Invest Ophthalmol Vis Sci

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.